Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subclinical Cytomegalovirus Reactivation in Patients With Newly Diagnosed or Relapsed ANCA-associated Vasculitis and Adverse Clinical Outcomes

NCT04916704 is registered in ClinicalTrials.gov with University Hospital Birmingham NHS Foundation Trust as lead sponsor.

NCT NCT04916704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04916704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subclinical Cytomegalovirus Reactivation in Patients With Newly Diagnosed or Relapsed ANCA-associated Vasculitis and Adverse Clinical Outcomes
Lead sponsor
University Hospital Birmingham NHS Foundation Trust
Phase
Observational
Overall status
Unknown status
Start date
April 19, 2022
Completion date
December 22, 2025
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anca associated vasculitis